We use cookies for a better user experience. Read our Privacy Policy

I Agree

Wearable Injectors Market

Wearable Injectors Market (Type - On-body Wearable Injectors, Off-body Wearable Injectors; Application - Oncology, Diabetes, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases; End use Industry - Hospitals, Clinics, Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

The presence of an ever-expanding healthcare industry has played an integral role in driving sales across the global wearable injectors market. It is integral for patients suffering from chronic diseases to get proper treatment and dosage at regular intervals of time. Wearable injectors have emerged as a self-scalable and self-administered technology that can help patients in ensuring regular intake of medical dosage. The need for administering the right amount of medical fluid has brought wearable injectors under the spotlight of attention. It is important for medical professionals and healthcare experts to inform the masses about the importance of using new-age technologies such as wearable injectors and other devices. The rising incidence of chronic diseases that necessitate the use of seamless technologies shall be a prominent driver of market demand in the times to follow.

In the presence of various new technologies that have come to the fore of healthcare sector, it is easy to popularise wearable injectors that can work in tandem with other devices and technologies. Delivery systems are an important component of treatment processes as they help in timely administration of medical doses. In light of these factors, it is safe to expect that the global wearable injectors market would tread along a lucrative pathway in the times to follow

wearable injectors market

Utility Served by Wearable Devices for Patients of Chronic Diseases

The next decade is expected to witness a surge in demand for wearable injectors, and this is an important consideration from the perspective of market growth. Wearable injectors can help in administering fluids in volumes larger than 2 mL, and this is a key proposition from the standpoint of market maturity. The subcutaneous nature of injecting bodily fluids through wearable injectors has also emerged as an important dynamic of market maturity. Furthermore, wearable injectors can be used to continuously deliver medical dosages over an extended period of time. These injectors and systems can be comfortably worn on the human body, creating new inlets for market growth and maturity.

The utility served by wearable injectors is the most prominent driver of demand within the global market. Several patients have started using wearable injectors as an important medical technology. Furthermore, the unprecedented need for microdevices in the healthcare industry has led doctors to scout for new technologies. In recent times, several experts have come to acknowledge the value of wearable injectors. Besides, the unprecedented demand for new-age technologies within medical diagnosis and treatment has also gained momentum.

Popularity of Wearable Technologies to Drive Demand

The growing relevance of wearable injectors and technologies has created new pathways for market growth and maturity. Several medical experts have pointed to the potential of wearable technologies in helping the medical industry in expediting treatment processes. Minor jumps and medical advances can be a source of relief for patients suffering from chronic illnesses. The hassle of undergoing multiple manual procedures for administration of medical fluids can be extremely traumatizing for patients. Patients suffering from heart diseases, cancer, and diabetes are especially prone to suffering from excessive stress due to frequent exposure to hospitals for minor fluid administration. Therefore, use of wearable injectors has emerged as an important dynamic of market growth and maturity in recent times. It is legit to expect that the growth graph of the global wearable injectors market would ascend along a lucrative pathway in the years to come by.

Need for Convenient Administration of Drugs

The use of wearable injectors has canny resemblance to the popularity of insulin pumps in the medical industry. Therefore, there is immense hope about mainstream usage of wearable injectors across the medical industry. In addition to this, the use of these injectors by patients at home has also given an impetus to market growth. The high costs associated with the use of manual administration lines has brought wearable injectors under the spotlight of attention. It is crucial for the masses to understand that administration of an infusion drug in the hospital will bear more cost and efforts than convenient administration of the drug through wearable injectors. This realization can help in popularising these injectors across a large population of people. Over the course of the next decade, it is legit to expect that the global wearable injectors market would attract voluminous revenues in the times to follow. Some of the common healthcare domains where wearable injectors are playing a revolutionary role are hemophilia, auto-immune, oncology, and multiple sclerosis. The commonality of IV infusion has compelled medical professionals to popularise wearable injectors. This can help in reducing the load on healthcare units and hospitals.

Growth of North America Market

On the basis of geography, the total volume of revenues within the North America wearable injectors market is projected to grow at a sound pace. Other regional pockets such as South America, Europe, Asia Pacific, and the Middle East have also witnessed a surge in demand for wearable injectors. The growth of the North America market can be pegged to advancements in medical research, wearable devices, and fluid administration. Furthermore, the growing focus on developing novel technologies for subcutaneous administration of fluids has also garnered the attention of the healthcare fraternity. Wearable injectors can be scaled for the amount of dosage and time that is apt for fluid administration. This is an important standpoint for popularising and promoting these injectors.

Some of the prominent vendors operating in the global wearable injectors market are F. Hoffmann-La Roche Ltd., Insulet Corporation, Ypsomed AG, Tandem Diabetes Care, Inc., and West Pharmaceutical Services, Inc.

The global wearable injectors market has been segmented as follows:

by Type

  • On-body Wearable Injectors
  • Off-body Wearable Injectors

by Application

  • Oncology
  • Diabetes
  • Autoimmune Disorders
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

by End-user

  • Hospitals
  • Clinics
  • Home Care Settings
  • Others

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Wearable Injectors Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface
     1.1. Report Scope and Market Segmentation
     1.2. Research Highlights

2. Assumptions and Research Methodology
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Wearable Injectors Market Snapshot

4. Market Overview
     4.1. Product Overview
     4.2. Market Opportunity Map
     4.3. Key Industry Events
     4.4. Global Wearable Injectors Market Size (US$ Mn) Forecast, 2016–2026
     4.5. Global Wearable Injectors Market Outlook
     4.6. Porter’s Five Forces Analysis
     4.7. Technology Trends
     4.8. Key Merger and Acquisitions

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
     5.3. Restraints
     5.4. Opportunities

6. Global Wearable Injectors Market Analysis, by Type
     6.1. Key Findings
     6.2. Introduction
     6.3. Global Wearable Injectors Market Value Share Analysis, by Type
     6.4. Global Wearable Injectors Market Forecast, by Type
            6.4.1. On-body Wearable Injectors
            6.4.2. Off-body Wearable Injectors
     6.5. Global Wearable Injectors Market Analysis, by Type
     6.6. Global Wearable Injectors Market Attractiveness Analysis, by Type

7. Global Wearable Injectors Market Analysis, by Application
     7.1. Key Findings
     7.2. Introduction
     7.3. Global Wearable Injectors Market Value Share Analysis, by Application, 2017 and 2026
     7.4. Global Wearable Injectors Market Forecast, by Application
            7.4.1. Oncology
            7.4.2. Diabetes
            7.4.3. Autoimmune Disorders
            7.4.4. Cardiovascular Diseases
            7.4.5. Infectious Diseases
            7.4.6. Others
     7.5. Global Wearable Injectors Market Analysis, by Application, 2016–2026
     7.6. Global Wearable Injectors Market Attractiveness Analysis, by Application, 2016–2026

8. Global Wearable Injectors Market Analysis, by End-user
     8.1. Introduction
     8.2. Key Findings
     8.3. Global Wearable Injectors Market Value Share Analysis, by End-user
     8.4. Global Wearable Injectors Market Forecast, by End-user
            8.4.1. Hospitals
            8.4.2. Clinics
            8.4.3. Home Care Settings
            8.4.4. Others
     8.5. Global Wearable Injectors Market Analysis, by End-user
     8.6. Global Wearable Injectors Market Attractiveness Analysis, by End-user

9. Global Wearable Injectors Market Analysis, by Region
     9.1. Global Wearable Injectors Market Scenario, by Region
     9.2. Global Wearable Injectors Market Value Share Analysis, by Region
     9.3. Global Wearable Injectors Market Forecast, by Region
            9.3.1. North America
            9.3.2. Europe
            9.3.3. Asia Pacific
            9.3.4. Latin America
            9.3.5. Middle East & Africa
     9.4. Global Wearable Injectors Market Attractiveness Analysis, by Region

10. North America Wearable Injectors Market Analysis
     10.1. Key Findings
     10.2. North America Wearable Injectors Market Overview
     10.3. North America Wearable Injectors Market Value Share Analysis, by Country
     10.4. North America Wearable Injectors Market Forecast, by Country
            10.4.1. U.S.
            10.4.2. Canada
     10.5. North America Wearable Injectors Market Value Share Analysis, by Type
     10.6. North America Wearable Injectors Market Forecast, by Type
            10.6.1. On-body Wearable Injectors
            10.6.2. Off-body Wearable Injectors
     10.7. North America Wearable Injectors Market Value Share Analysis, by Application
     10.8. North America Wearable Injectors Market Forecast, by Application
            10.8.1. Oncology
            10.8.2. Diabetes
            10.8.3. Autoimmune Disorders
            10.8.4. Cardiovascular Diseases
            10.8.5. Infectious Diseases
            10.8.6. Others
     10.9. North America Wearable Injectors Market Value Share Analysis, by End-user
     10.10. North America Wearable Injectors Market Forecast, by End-user
            10.10.1. Hospitals
            10.10.2. Clinics
            10.10.3. Home Care Settings
            10.10.4. Others
     10.11. North America Wearable Injectors Market Attractiveness Analysis

11. Europe Wearable Injectors Market Analysis
     11.1. Key Findings
     11.2. Europe Wearable Injectors Market Overview
     11.3. Europe Wearable Injectors Market Value Share Analysis, by Country/Sub-region
     11.4. Europe Wearable Injectors Market Forecast, by Country/Sub-region
            11.4.1. Germany
            11.4.2. U.K.
            11.4.3. France
            11.4.4. Italy
            11.4.5. Spain
            11.4.6. Rest of Europe
     11.5. Europe Wearable Injectors Market Value Share Analysis, by Type
     11.6. Europe Wearable Injectors Market Forecast, by Type
            11.6.1. On-body Wearable Injectors
            11.6.2. Off-body Wearable Injectors
     11.7. Europe Wearable Injectors Market Value Share Analysis, by Application
     11.8. Europe Wearable Injectors Market Forecast, by Application
            11.8.1. Oncology
            11.8.2. Diabetes
            11.8.3. Autoimmune Disorders
            11.8.4. Cardiovascular Diseases
            11.8.5. Infectious Diseases
            11.8.6. Others
     11.9. Europe Wearable Injectors Market Value Share Analysis, by End-user
     11.10. Europe Wearable Injectors Market Forecast, by End-user
            11.10.1. Hospitals
            11.10.2. Clinics
            11.10.3. Home Care Settings
            11.10.4. Others
     11.11. Europe Wearable Injectors Market Attractiveness Analysis

12. Asia Pacific Wearable Injectors Market Analysis
     12.1. Key Findings
     12.2. Asia Pacific Wearable Injectors Market Overview
     12.3. Asia Pacific Wearable Injectors Market Value Share Analysis, by Country/Sub-region
     12.4. Asia Pacific Wearable Injectors Market Forecast, by Country/Sub-region
            12.4.1. China
            12.4.2. Japan
            12.4.3. India
            12.4.4. Australia & New Zealand
            12.4.5. Rest of Asia Pacific
     12.5. Asia Pacific Wearable Injectors Market Value Share Analysis, by Type
     12.6. Asia Pacific Wearable Injectors Market Forecast, by Type
            12.6.1. On-body Wearable Injectors
            12.6.2. Off-body Wearable Injectors
     12.7. Asia Pacific Wearable Injectors Market Value Share Analysis, by Application
     12.8. Asia Pacific Wearable Injectors Market Forecast, by Application
            12.8.1. Oncology
            12.8.2. Diabetes
            12.8.3. Autoimmune Disorders
            12.8.4. Cardiovascular Diseases
            12.8.5. Infectious Diseases
            12.8.6. Others
     12.9. Asia Pacific Wearable Injectors Market Value Share Analysis, by End-user
     12.10. Asia Pacific Wearable Injectors Market Forecast, by End-user
            12.10.1. Hospitals
            12.10.2. Clinics
            12.10.3. Home Care Settings
            12.10.4. Others
     12.11. Asia Pacific Wearable Injectors Market Attractiveness Analysis

13. Latin America Wearable Injectors Market Analysis
     13.1. Key Findings
     13.2. Latin America Wearable Injectors Market Overview
     13.3. Latin America Wearable Injectors Market Value Share Analysis, by Country/Sub-region
     13.4. Latin America Wearable Injectors Market Forecast, by Country/Sub-region
            13.4.1. Brazil
            13.4.2. Mexico
            13.4.3. Rest of Latin America
     13.5. Latin America Wearable Injectors Market Value Share Analysis, by Type
     13.6. Latin America Wearable Injectors Market Forecast, by Type
            13.6.1. On-body Wearable Injectors
            13.6.2. Off-body Wearable Injectors
     13.7. Latin America Wearable Injectors Market Value Share Analysis, by Application
     13.8. Latin America Wearable Injectors Market Forecast, by Application
            13.8.1. Oncology
            13.8.2. Diabetes
            13.8.3. Autoimmune Disorders
            13.8.4. Cardiovascular Diseases
            13.8.5. Infectious Diseases
            13.8.6. Others
     13.9. Latin America Wearable Injectors Market Value Share Analysis, by End-user
     13.10. Latin America Wearable Injectors Market Forecast, by End-user
            13.10.1. Hospitals
            13.10.2. Clinics
            13.10.3. Home Care Settings
            13.10.4. Others
     13.11. Latin America Wearable Injectors Market Attractiveness Analysis

14. Middle East and Africa Wearable Injectors Market Analysis
     14.1. Key Findings
     14.2. Middle East and Africa Wearable Injectors Market Overview
     14.3. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Country/Sub-region
     14.4. Middle East and Africa Wearable Injectors Market Forecast, by Country/Sub-region
            14.4.1. GCC Countries
            14.4.2. South Africa
            14.4.3. Rest of MEA
     14.5. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Type
     14.6. Middle East and Africa Wearable Injectors Market Forecast, by Type
            14.6.1. On-body Wearable Injectors
            14.6.2. Off-body Wearable Injectors
     14.7. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Application
     14.8. Middle East and Africa Wearable Injectors Market Forecast, by Application
            14.8.1. Oncology
            14.8.2. Diabetes
            14.8.3. Autoimmune Disorders
            14.8.4. Cardiovascular Diseases
            14.8.5. Infectious Diseases
            14.8.6. Others
     14.9. Middle East and Africa Wearable Injectors Market Value Share Analysis, by End-user
     14.10. Middle East and Africa Wearable Injectors Market Forecast, by End-user
            14.10.1. Hospitals
            14.10.2. Clinics
            14.10.3. Home Care Settings
            14.10.4. Others
     14.11. Middle East and Africa Wearable Injectors Market Attractiveness Analysis

15. Competition Landscape
     15.1. Wearable Injectors Market Share Analysis By Company, 2017
     15.2. Company Profiles
            15.2.1. Becton, Dickinson and Company
                     15.2.1.1. Company Profiles
                     15.2.1.2. Business Overview
                     15.2.1.3. Strategic Overview
                     15.2.1.4. SWOT Analysis
            15.2.2. F. Hoffmann-La Roche Ltd.
                     15.2.2.1. Company Profiles
                     15.2.2.2. Business Overview
                     15.2.2.3. Strategic Overview
                     15.2.2.4. SWOT Analysis
            15.2.3. Tandem Diabetes Care, Inc.
                     15.2.3.1. Company Profiles
                     15.2.3.2. Business Overview
                     15.2.3.3. Strategic Overview
                     15.2.3.4. SWOT Analysis
            15.2.4. Insulet Corporation
                     15.2.4.1. Company Profiles
                     15.2.4.2. Business Overview
                     15.2.4.3. Strategic Overview
                     15.2.4.4. SWOT Analysis
            15.2.5. Ypsomed AG
                     15.2.5.1. Company Profiles
                     15.2.5.2. Business Overview
                     15.2.5.3. Strategic Overview
                     15.2.5.4. SWOT Analysis
            15.2.6. West Pharmaceutical Services, Inc.
                     15.2.6.1. Company Profiles
                     15.2.6.2. Business Overview
                     15.2.6.3. Strategic Overview
                     15.2.6.4. SWOT Analysis
            15.2.7. CeQur SA.
                     15.2.7.1. Company Profiles
                     15.2.7.2. Business Overview
                     15.2.7.3. Strategic Overview
                     15.2.7.4. SWOT Analysis
            15.2.8. Debiotech S.A.
                     15.2.8.1. Company Profiles
                     15.2.8.2. Business Overview
                     15.2.8.3. Strategic Overview
                     15.2.8.4. SWOT Analysis
            15.2.9. Sensile Medical AG
                     15.2.9.1. Company Profiles
                     15.2.9.2. Business Overview
                     15.2.9.3. Strategic Overview
                     15.2.9.4. SWOT Analysis
            15.2.10. SteadyMed Therapeutics, Inc.
                     15.2.10.1. Company Profiles
                     15.2.10.2. Business Overview
                     15.2.10.3. Strategic Overview
                     15.2.10.4. SWOT Analysis

List of Tables

Table 01: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 02: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global Wearable Injectors Market Revenue (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 07: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 08: North America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 10: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 11: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 12: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 15: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 16: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 17: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 19: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 20: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 23: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 24: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global Wearable Injectors Market Snapshot
Figure 02: Global Wearable Injectors Market Size (US$ Mn) Forecast, 2016–2026
Figure 03: Market Value Share, by Type (2017)
Figure 04: Market Value Share, by Application (2017)
Figure 05: Market Value Share, by Region (2017)
Figure 06: Figure 06: Market Value Share, by End-user (2017)
Figure 07: Global Wearable Injectors Market Value Share Analysis, by Type, 2017 and 2026
Figure 08: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by On-body wearable injectors, 2016–2026
Figure 09: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Off-body wearable injectors, 2016–2026
Figure 10: Global Wearable Injectors Market Attractiveness Analysis, by Type, 2016–2026
Figure 11: Global Wearable Injectors Market Value Share Analysis, by Application, 2016 and 2025
Figure 12: Global Wearable Injectors Market Size (US$ Mn), by Oncology, 2016–2026
Figure 13: Global Wearable Injectors Market Size (US$ Mn), by Diabetes, 2016–2026
Figure 14: Global Wearable Injectors Market Size (US$ Mn), by Autoimmune Disorders, 2016–2026
Figure 15: Global Wearable Injectors Market Size (US$ Mn), by Cardiovascular Diseases, 2016–2026
Figure 16: Global Wearable Injectors Market Size (US$ Mn), by Infectious Diseases, 2016–2026
Figure 17: Global Wearable Injectors Market Size (US$ Mn), by Others, 2016–2026
Figure 18: Global Wearable Injectors Market Attractiveness Analysis, by Application, 2018–2026
Figure 19: Global Wearable Injectors Market Value Share Analysis, by End-user, 2017 and 2026
Figure 20: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016–2026
Figure 21: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2016–2026
Figure 22: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Home Care Settings, 2016–2026
Figure 23: Global Wearable Injectors Market Value (US$ Mn) and Y-o-Y Growth, by Others (Physician office, etc.), 2016–2026
Figure 24: Global Wearable Injectors Market Attractiveness Analysis, by End-user, 2016–2026
Figure 25: Global Wearable Injectors Market Value Share, by Region, 2017 and 2026
Figure 26: Global Wearable Injectors Market Attractiveness, by Region, 2018–2026
Figure 27: North America Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 28: North America Wearable Injectors Market Attractiveness, by Country, 2018–2026
Figure 29: North America Wearable Injectors Market Value Share, by Country, 2017 and 2026
Figure 30: North America Wearable Injectors Market Value Share, by Type, 2017 and 2026
Figure 31: North America Wearable Injectors Market Value Share, by Application, 2017 and 2026
Figure 32: North America Wearable Injectors Market Value Share, by End-user, 2017 and 2026
Figure 33: North America Wearable Injectors Market Attractiveness, by Type, 2016–2026
Figure 34: North America Wearable Injectors Market Attractiveness, by End-user, 2016–2026
Figure 35: North America Wearable Injectors Market Attractiveness, by Application, 2016–2026
Figure 36: Europe Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 37: Europe Wearable Injectors Market Attractiveness, by Country, 2018–2026
Figure 38: Europe Wearable Injectors Market Value Share, by Country, 2017 and 2026
Figure 39: Europe Wearable Injectors Market Value Share, by Type, 2017 and 2026
Figure 40: Europe Wearable Injectors Market Value Share, by Application, 2017 and 2026
Figure 41: Europe Wearable Injectors Market Value Share, by End-user, 2017 and 2026
Figure 42: Europe Wearable Injectors Market Attractiveness, by Type, 2016–2026
Figure 43: Europe Wearable Injectors Market Attractiveness, by End-user, 2016–2026
Figure 44: Europe Wearable Injectors Market Attractiveness, by Application, 2016–2026
Figure 45: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 46: Asia Pacific Wearable Injectors Market Attractiveness, by Country, 2018–2026
Figure 47: Asia Pacific Wearable Injectors Market Value Share, by Country, 2017 and 2026
Figure 48: Asia Pacific Wearable Injectors Market Value Share, by Type, 2017 and 2026
Figure 49: Asia Pacific Wearable Injectors Market Value Share, by Application, 2017 and 2026
Figure 50: Asia Pacific Wearable Injectors Market Value Share, by End-user, 2017 and 2026
Figure 51: Asia Pacific Wearable Injectors Market Attractiveness, by Type, 2016–2026
Figure 52: Asia Pacific Wearable Injectors Market Attractiveness, by End-user, 2016–2026
Figure 53: Asia Pacific Wearable Injectors Market Attractiveness, by Application, 2016–2026
Figure 54: Latin America Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 55: Latin America Wearable Injectors Market Attractiveness, by Country, 2018–2026
Figure 56: Latin America Wearable Injectors Market Value Share, by Country, 2017 and 2026
Figure 57: Latin America Wearable Injectors Market Value Share, by Type, 2017 and 2026
Figure 58: Latin America Wearable Injectors Market Value Share, by Application, 2017 and 2026
Figure 59: Latin America Wearable Injectors Market Value Share, by End-user, 2017 and 2026
Figure 60: Latin America Wearable Injectors Market Attractiveness, by Type, 2016–2026
Figure 61: Latin America Wearable Injectors Market Attractiveness, by End-user, 2016–2026
Figure 62: Latin America Wearable Injectors Market Attractiveness, by Application, 2016–2026
Figure 63: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 64: Middle East & Africa Wearable Injectors Market Attractiveness, by Country, 2018–2026
Figure 65: Middle East & Africa Wearable Injectors Market Value Share, by Country, 2017 and 2026
Figure 66: Middle East & Africa Wearable Injectors Market Value Share, by Type, 2017 and 2026
Figure 67: Middle East & Africa Wearable Injectors Market Value Share, by Application, 2017 and 2026
Figure 68: Middle East & Africa Wearable Injectors Market Value Share, by End-user, 2017 and 2026
Figure 69: Middle East & Africa Wearable Injectors Market Attractiveness, by Type, 2016–2026
Figure 70: Middle East & Africa Wearable Injectors Market Attractiveness, by End-user, 2016–2026
Figure 71: Middle East & Africa Wearable Injectors Market Attractiveness, by Application, 2016–2026
Figure 72: Becton, Dickinson and Company, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 73: Becton, Dickinson and Company, Breakdown of Net Sales, By Region (Pharmaceutical Segment), 2017
Figure 74: Becton, Dickinson and Company, R&D Intensity (%) – Company Level or Segment Level, 2014–2017
Figure 75: Hoffmann-La Roche Ltd., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 76: Hoffmann-La Roche Ltd., Breakdown of Net Sales, By Region (Pharmaceutical Segment), 2017
Figure 77: Hoffmann-La Roche Ltd., R&D Intensity (%) – Company Level or Segment Level, 2014–2017
Figure 78: Tandem Diabetes Care, Inc., R&D Intensity (%) – Company Level or Segment Level, 2014–2017
Figure 79: Tandem Diabetes Care, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 80: Insulet Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 81: Insulet Corporation, Breakdown of Net Sales, By Region, 2016
Figure 82: Insulet Corporation, R&D Intensity (%) – Company Level or Segment Level, 2014–2017
Figure 83: Ypsomed AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 84: Ypsomed AG, Breakdown of Net Sales, By Region, 2016
Figure 85: Ypsomed AG, R&D Intensity (%) – Company Level or Segment Level, 2013–2016
Figure 86: West Pharmaceutical Services, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 87: West Pharmaceutical Services, Inc., Breakdown of Net Sales, By Region, 2016
Figure 88: West Pharmaceutical Services, Inc., R&D Intensity (%) – Company Level or Segment Level, 2014–2017

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

814

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved